Replies to post #225421 on Biotech Values

[DewDiligence]

SOBI.ST acquires DOVA for $27.50/sh cash + CVR:

https://finance.yahoo.com/news/dova-pharmaceuticals-acquired-swedish-orphan-060000190.html

The $27.50 price is a 36% premium to Friday’s close. The nominal deal value is $810M (excluding the CVR).